Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
As clinicians and scientists gather more data on the clinical trajectory of COVID-19 and the biology of its causative agent, the SARS-CoV-2 virus, novel strategies are needed to integrate these data to inform new therapies. A recent study by Howell et al. introduces a network model of viral-host int...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-04-01
|
| Series: | npj Digital Medicine |
| Online Access: | https://doi.org/10.1038/s41746-022-00599-5 |